INTRODUCTION
Two major processes presumably located in the canalicular membrane initiate and regulate hepatocytic bile flow (1, 2) . In addition to active secretion of bile acids, there is a quantitatively important fraction of bile flow which may be dependent upon the active transport of sodium across the canalicular membrane (3) (4) (5) (6) . Since in mammalian cells a major proportion of sodium transport is regulated by sodium-potas-hypothesized that activity of this enzyme controls bile salt-independent bile flow (7, 8) .
Presently it is not possible to measure transport of sodium across the canalicular membrane because of the inaccessibility of this structure to direct examination. Although indirect studies suggest that alterations in bile salt-independent bile flow are due to changes in (Na+-K+)-ATPase activity, conclusive evidence is lacking. Studies of the effects of cardiac glycosides and ethacrynic acid, inhibitors of (Na+-K+)-ATPase, are conflicting in both intact animals and the isolated perfused rat liver (8) (9) (10) (11) .
A useful technique for elucidating the possible physiological role of rate-limiting enzymes is to correlate changes in enzyme activity with changes in the function in question (12) . Correlation of changes in (Na+-K+)-ATPase activity with bile flow would support (but not prove) a role for the sodium pump in regulating bile flow. Since phenobarbital produces a marked increase in bile salt-independent flow, in addition to its well-known effects on drug metabolism (13-16), we studied its effect on (Na+-K+)-ATPase. The present investigation was designed to answer three questions: (a) whether phenobarbital administration increases (Na+-K+)-ATPase activity; (b) if (Na+-K+)-ATPase activity is increased, whether de novo protein synthesis is required; and (c) to ascertain the correlation, if any, between (Na+-K+)-ATPase activity and bile flow. The results indicate that an adaptive increase in (Na+-K+)-ATPase is induced by phenobarbital which depends upon new protein synthesis. Furthermore, correlation of changes in (Na+-K+)-ATPase activity with alterations in bile flow supports the concept that the sodium pump is involved at least in part in regulation of bile flow. METHODS Animals and materials. Male Sprague-Dawley rats weighing 180-250 g (Charles River Breeding Laboratories, Inc., Wilmington, Mass.) allowed free accees to Purina Rat Chow (Ralston Purina Co., St. Louis, Mo.) and water were used in all experiments. Rats were kept in wire-mesh drop-through cages with aspen wood chip bedding (American Exelsior Co., Arlington, Tex.) and altemating 12 h of light and darkness. Insecticides were not used in the animal quarters. One group of rats was made hypothyroid by thyroidectomy at Charles River Breeding Laboratories and injection of 1 Ci of carrier-free 13'Na-iodide (Abbott Laboratories, South Pasadena, Calif.) given intraperitoneally. Thyroidectomized rats were maintained on drinking water which contained 1.0% calcium gluconate and were studied 4-6 wk later.
Liver surface membranes were prepared according to Neville (17) through step 12 as described by Pohl et al. (18) . Mitochondrial, lysosomal, and microsomal fractions were prepared by modification ofthe procedure of Evans and Gurd (19) as previously described (20) . Kidney homogenates were prepared in 1 mM NaHCO3 after removal of the capsule. Homogenates from the proximal small intestine were prepared from the first 20 cm of small intestine and distal small intestinal homogenates were obtained from the last 850 F. R. Simon, E. Sutherland, and L. Accatino 20 cm of small intestine. The entire small intestine was removed, perfused with 1 mM NaHCO3 to remove contents, and after opening the lumen the mucosa was gently scraped with a glass slide. Bodansky (20) . IDPase (EC 3.6.1.6) was determined without the addition of deoxycholate, which inhibits the liver surface membrane isoenzyme, according to Novikoff and Heus (31, 32 TCA and collected on glass fiber disks (Whatman Inc., Clifton, N. J.). Samples were serially washed with 5 ml each of ethanol, ether, acetone, and TCA. The disks were transferred to scintillation vials and protein was solubilized with 0.5 ml protosol (New England Nuclear, Boston, Mass. (36) . Significance of differences among estimated parameters was determined by a two-sample test or a Z score (37) . P values equal to or less than 0.05 were considered significant.
Chemical analysis. Bile salts were determined by the enzymatic method of Talalay (38) . Serum thyroxine concentration and thyroxine binding was determined by the displacement method (Thiolute, Ames Co., Elkhart, Ind. 
RESULTS
Characteristics and distribution of(Na+-K+)-ATPase in rat liver. Hepatic (Na+-K+)-ATPase activity is linear with increasing protein concentrations to at least 500 /.g (Fig. IA) but for only 7.5 min with time ( Fig.   1B) under the conditions described in Methods. Therefore, since (Na+-K+)-ATPase is a heat-labile enzyme, 5-min incubation times were used to obtain reliable results. The apparent half-maximum activation constant (Kin) with ATP as substrate is 1.2+0.2 mM (Table I) , a value close to that described recently for rat skeletal muscle (39) . Since freeze-thawing in 1 mM NaHCO3 results in significantly increased (Na+-K+)-ATPase activity compared to the original assay, we examined whether this modification altered the affinity of the membrane-bound enzyme for substrate or rather permits increased substrate availability. The results shown in Table I demonstrate that the Vmax for (Na+-K+)-ATPase is significantly increased by freeze-thawing, but the apparent Km is unaltered, Liver surface membrane fractions prepared according to Neville (17) , were washed with ice-cold normal saline before storage. Values are mean+SEM. The number in parentheses is the number of individual liver surface membrane preparations studied. The best-fit line of activity was identified by nonlinear least-squares regression (36) . - (45) Glucose--6-Phosphatose (n) (n) (O 5 Nuclear Mito-
FIGuRE 2 Relative activities of 5'-nucleotidase, (Na+-K+)-ATPase, and glucose-6-phosphatase in liver subcellulr fractions. Subcellular fractions were prepared and the enzyme activities measured as described under Methods. The values in parentheses represent percent recovery of enzymes in each fraction.
consistent with the suggestion that activation is due to increased access of substrate to reactive sites on the enzyme (40) .
Since physiological studies suggest a role for (Na+-K+)-ATPase at the surface membrane, the subcellular distribution of the enzyme was examined. The purity of hepatic subcellular fractions was monitored by measuring 5'-nucleotidase and glucose-6-phosphatase activities (Fig. 2 (27, 41) . Liver surface membrane fractions are similarly enriched in both (Na+-K+)-ATPase and 5'-nucleotidase activities. In contrast, intracellular membrane fractions containing nuclei, mitochondria, lysosomes, and microsomes show less (Na+-K+)-ATPase activity than surface membranes (Fig. 2 ). Total recovery of hepatic (Na+-K+)-ATPase is highest in the microsomal fraction similar to results obtained in other tissues (42, 43) . However, this probably represents sedimentation ofsurface membrane elements in this fraction rather than its primary location, for (Na+-K+)-ATPase activity is high in the surface membrane fraction when glucose-6-phosphatase activity is very low. Thus, these studies support a primary surface membrane location for (Na+-K+)-ATPase. Effect of phenobarbital administration on hepatic (Na+-K+)-ATPase activity. Administration of phenobarbital (8 mg/100 g body wt for 5 days significantly increases (Na+-K+)-ATPase specific activity in liver homogenates compared to saline-injected controls (Fig.  3) . Furthermore, this increased activity is preserved in the surface membrane fraction, but to a lesser degree because of lability of the induced enzyme (rather than altered distribution). Lability of the enzyme is shown by its reduced recovery in membrane pellets prepared by centrifugation of homogenates at 100,000g for 1 h in phenobarbital-treated rats (62 +±5%) compared to controls (90±7%) (P < 0.001).
Since phenobarbital may induce many changes in the liver surface membrane which might lead to an apparent in vitro stimulation of (Na+-K+)-ATPase, we compared the relative change in enzyme activities of freshly prepared liver surface membrane fractions to that observed after freeze-thaw. The results shown in Table II indicate that although specific activities are greater after freeze-thawing, the percentage of change is comparable.
To determine whether phenobarbital administration alters recovery of the liver surface membrane fraction, recovery of protein and the relative enzyme activities for representative marker enzymes from the endoplasmic reticulum (glucose-6-phosphatase), mitochondria (cytochrome c oxidase), and the canalicular surface membrane (Mg++-ATPase) were compared to controls (Table III ). These studies demonstrate that phenobarbital does not alter the recovery or apparent purity of liver surface membrane fractions.
Effect of phenobarbital on liver surface membrane enzymes and (Na+-K+)-ATPase activity. To investigate whether phenobarbital administration selectively increases (Na+-K+)-ATPase or whether it also increases other surface membrane-bound enzymes, the activities of several phosphatase enzymes in isolated liver surface membrane fractions from control and phenobarbital-treated rats were examined. Phenobarbital did not significantly alter Mg++-ATPase but it reduced IDPase, alkaline phosphatase, and 5'-nucleotidase activities each to a different extent (Fig. 4) . Thus, phenobarbital treatment increases (Na+-K+)-ATPase activity while other surface membrane phosphatase activities are either unaltered or decreased.
(Na+-K+)-ATPase is present in the surface membrane of most cells (25) and has been shown to adapt to increased sodium loads (43, 44) , glucocorticoids (45, 46) , and thyroid hormone (21, 47) . The tissue specificity of phenobarbital induction was therefore examined in the small intestine, kidney, and skeletal muscle. number of sites may be revealed by a decreased apparentKKm alone or in combination with increased Vmax, while an increase in the total number of enzyme sites would result in an increased Vmax. In liver surface membranes from phenobarbital-treated rats, Vmax was increased 2.5-fold (P < 0.001), and the apparent Km was not significantly changed (Fig. 6) . The increased Vmax is probably due to an increased number of enzyme molecules rather than activation, a conclusion supported by the finding that mixing the liver cytosol and surface membranes from phenobarbitaltreated and normal animals or the addition of 0.5 or 1 ,uM phenobarbital directly to the assay did not significantly alter (Na+-K+)-ATPase activity. Effect of cycloheximide on phenobarbital-enhanced (Na+-K+)-ATPase activity. The mechanism of phenobarbital-enhanced (Na+-K+)-ATPase activity was further investigated by examining the effect of cycloheximide, a potent inhibitor of protein synthesis (48, 49) on the changes in enzyme activity (Fig. 7) Effect of hypothyroidism on hepatic (Na+-K+)-ATPase activity and bile flow and their response to phenobarbital administration. Thyroid hormone is an important regulator of hepatic (Na+-K+)-ATPase activity and bile flow (21, 54, 55) . Since phenobarbital administration increases hepatic accumulation and metabolism of thyroxine (56, 57) it seemed possible that the selective induction of sodium transport sites may be mediated through thyroid hormone. Fig. 9 demonstrates that thyroidectomy reduces (Na+-K+)-ATPase and bile flow 41 (Table IV) , during phenobarbital administration both liver surface membrane (Na+-K+)-ATPase activity and basal bile flow were doubled (P < 0.001) and were now not significantly different from control. Time course of phenobarbital-induced changes in hepatic (Na+-K+)-ATPase activity, bile flow, electrolyte and bile acid excretion, and liver weight. To examine further the relationship of hepatic (Na+-K+)-ATPase to bile flow the sequence of changes in enzyme activity, bile flow, and biliary electrolytes was determined during 5 days of daily phenobarbital administration (Table V) . Bile flow, as well as hepatic (Na+-K+)-ATPase, is increased as early as 14 h after administration of phenobarbital and increase proportionally for 2 days. As previously shown, bile flow peaks at 48 h and does not increase further despite continued administration of phenobarbital (14) . In contrast, (Na+-K+)-ATPase activity continues to rise for 5 days. Consistent with increased canalicular (Na+-K+)-ATPase activity, biliary sodium concentrations were not significantly altered, but potassium concentrations were lower than control at all time periods (P < 0.05). Changes in (Na+-K+)-ATPase and bile flow are apparently independent of bile acid excretion, which was not significantly altered. Relative liver weight neither increased to the same degree nor in the same time sequence as (Na+-K+)-ATPase and bile flow.
DISCUSSION
(Na+-K+)-ATPase, which is the enzymatic expression of the sodium pump (22, 25, 58) , is responsible for maintenance of Na+ and K+ gradients and cell volume (59, 60) . The activity of this enzyme in a number of tissues adapts to varying cellular requirements for transport of Na+ and K+, indicating that it is an important factor in determining cation and water transport. If the hypothesis that sodium is actively transported from hepatocytes into bile is valid, bile secretion should depend on the activity of (Na+-K+)-ATPase. The present study demonstrates that phenobarbital selectively induces hepatic (Na+-K+)-ATPase activity, which correlates closely with bile flow.
Previous studies with known inhibitors of (Na+-K+)-ATPase such as cardiac glycosides and ethaerynic acid have shown confiicting effects on bile flow. Such results may result from the rat's large capacity to excrete these drugs (61, 62) , its resistance to inhibition of (Na+-K+)-ATPase (63), or lastly to the possible location of cardiac glycoside binding sites on the biliary rather than the sinusoidal surface where they are not available to sufficient concentrations of inhibitors. Therefore, we examined whether phenobarbital, a powerful inducer of bile salt-independent flow and biliary sodium excretion, is also associated with increased (Na+-K+)-ATPase activity. Determination of (Na+-K+)-ATPase in liver homogenates is difficult because of the high background of Mg++-ATPase and the relatively low (Na+-K+)-ATPase activity. Bakkeren and Bonting (64) incuibated liver homogenates with urea to inhibit Mg++-ATPase to distinguish changes in (Na+-K+)-ATPase under different experimental conditions. Since the enzyme system is localized in membranes, deoxycholate has been successfully used to increase (Na+-K+)-ATPase activity, permitting access of substrate to the enzyme site (65) . But, in the liver this detergent inhibits activity (66) , and therefore we used the techni(lue of freezethawing samples in hypotonic NaHCO3 to increase activity. Since Vmax increases, indicating an increased number of transport sites, and the apparent Km is unaltered, this method apparently increases activity without altering the structure of the enzyme.
The highest (Na+-K+)-ATPase specific activity was obtained in liver surface membrane fractions enriched in bile canaliculi. Both specific activity and percent recovery co-isolate with 5'-nucleotidase, an established liver surface membrane enzyme. In addition, the distribution of (Na+-K+)-ATPase is different than the microsomal enzyme glucose-6-phosphatase consistent with sedimentation of liver surface membrane fragments with the microsomal fraction (42, 67) . Although these sttudies do not clarify whether (Na+-K+)-ATPase is located on the sinusoidal, canalicular, or on both poles of the hepatic parenchyma cell, at the very least the finding of greatly increased (Na+-K+)-ATPase activity in liver surface membrane fractions enriched in bile canaliculi suggests that the soditum pump is located at a site where it can regulate biliary excretion of sodium (23) .
Development of an assay with threefold increased activity permits re-examination of the question whether phenobarbital increases hepatic (Na+-K+)-ATPase activity. In contrast to findings of previous studies (68) (69) (70) , administration of phenobarbital significantly increased (Na+-K+)-ATPase activity almost twofold in liver surface membrane fractions. Increased (Na+-K+)-ATPase is not due to isolation of different surface membrane fractions in the treated animals, as shown by the threefold increase in total liver homogenates (Na+-K+)-ATPase activity and the uinaltered recovery of surface membrane protein and relative enrichement of membrane marker enzymes (Table II) .
Increased hepatic (Na+-K+)-ATPase activity is selective. Other membrane phosphatases as well as sodium pump activity in the small intestines, kidney, and skeletal musele are either unaltered or reduced. Although the mechanism is not clear, heterogeneous tissue responses of (Na+-K+)-ATPase after administration of thyroid hormone and mineralocorticoids has been reported for colon and brain (21, 46) . In addition, the differential increase in hepatic (Na+-K+)-ATPase compard to Mg++ATPase and other phosphatases suggests phenobarbital may induce new sodium transport sites per unit of surface membrane protein.
Enhanced (Na+-K+)-ATPase activity induced by phenobarbital administration may result from changes in enzyme kinetic properties, activation of a fixed number of enzyme molecules, or induction of enzyme protein. Since isolation, purification, and immunological (Iuantitation of hepatic (Na+-K+)-ATPase has not been achieved, studies of kinetic analysis from partially purified surface membrane fractions was utilized to examine whether phenobarbital altered kinetic properties or increased the number of active molecules. If phenobarbital increased the total number of sites, an increase in Vmax of the enzyme would be observed while activation will decrease Km. Utilizing ATP as the variable in both control and phenobarbitaltreated animals, hyperbolic kinetics were obtained. The Km for ATP was not significantly altered, but Vmax was increased, consistent with an increased number of sodium transport sites.
An apparent increased number of (Na+-K+)-ATPase sites can result from activation of latent enzyme as well as induction of new sodium transport sites. One way to distinguish these alternatives is to examine whether inhibition of protein synthesis required for induction blocks the increase in (Na+-K+)-ATPase. Cycloheximide, which inhibits polypeptide elongation (49), decreases hepatic protein synthesis and prevents phenobarbital enhancement of (Na+-K+)-ATPase and bile flow. Significantly, cyclohexmide when given alone does not alter basal (Na+-K+)-ATPase activity, bile flow, or bile acid excretion. Further evidence against activation of latent sites was obtained from the experiments showing that phenobarbital added in vitro failed to change activity and that liver cytosol and membrane fractions from phenobarbital-treated animals failed to activate enzyme activity in control liver surface membrane. Thus, although further studies are needed to confirm an increased number of sodium transport sites utilizing such methods as binding of [3H] ouabain and the sodium-dependent incorporation of 32P from [y32P]ATP, these studies support the conclusion that phenobarbital induces de novo protein synthesis of (Na+-K+)-ATPase macromolecules.
To determine whether phenobarbital increases new synthesis or rather stabilizes preformed (Na+-K+)-ATPase molecules, degradation rate constants in the presence and absence of drug were estiamted. Consistent with previous studies (53, 71) (21) have demonstrated that thyroid hormone increases (Na+-K+)-ATPase and Layden and Boyer (55) recently have shown that this altered enzyme activity is associated with changes in bile salt independent flow. Since thyroid hormone has also been implicated in the increased hepatic (Na+-K+)-ATPase activity of chronic alcohol ingestion in rats (77, 78) , we investigated whether thyroxine may also mediate the hepatic response to phenobarbital. Hypothyroidism was confirmed by unmeasurable serum thyroxine binding capacity in untreated and phenobarbital-treated rats. Thyroidectomy proportionally reduced both (Na+-K+)-ATPase and bile flow to 50% of control as reported by others (55) . In this setting of thyroid deficiency, phenobarbital doubled (Na+-K+)-ATPase activity and basal bile flow, indicating that the pathways mediating phenobarbital enhancement are intact in the hypothyroid rat. However, phenobarbital does not increase either (Na+-K+)-ATPase or bile flow to levels found in phenobarbital-treated euthyroid animals, suggesting that thyroid hormone may play a permissive role in phenobarbital induction.
The present studies do not clarify whether phenobarbital has a specific effect on (Na+-K+)-ATPase or whether changes in activity are mediated by changes in intracellular sodium and (or) potassium concentrations due to increased passive movements of these cations or, alternatively, by an increase in the ATP: ADP ratio, an effect of phenobarbital on mitochondrial oxidative phosphorylation. Studies measuring the temporal relationship of intracellular cations and nucleotide concentrations to sodium pump activity are needed to answer these questions.
If activiation of the sodium pump mediates bile salt-independent flow, changes in bile flow should be temporally related to changes in (Na+-K+)-ATPase activity. Analyses of basal bile flow with daily administration of phenobarbital were similar to previous studies revealing a latent period of 14 h and an increase in flow to a maximum value at 2 days which remained relatively unchanged in spite of continued treatment (14, 50) . The time course in hepatic (Na+-K+)-ATPase was in phase for only the first 2 days, but continued to rise reaching a plateau level at 4 days. Thus, both (Na+-K+)-ATPase and basal bile flow are proportional for 48 h, supporting the inference that basal (Na+-K+)-ATPase activity mediates an important part of bile salt-independent flow by placing a ceiling on the rate of sodium excretion. However, when basal sodium pump activity is increased greater than twofold, other factors apparently become rate limiting for sodium excretion. The lack of correlation after 2 days of phenobarbital treatment may be due to decreasing efficiency of the sodium pump (i.e., the coupling ratio of Na+:K+:ATP is changed) or increased passive permeability of the canalicular 858 F. R. Simon, E. Sutherland, and L. Accatino membrane to Na+ so that less osmotic activity is present. It has been suggested that the dissociation of increased (Na+-K+)-ATPase and radiolabeled rubiditum transport observed in experimental chronic alcohol ingestion in rats may be due to alterations in both of these mechanisms (78) . Fig. 10 summarizes the relationship in the experimental situations described in the present paper between basal bile flow and (Na+-K+)-ATPase activity per gram of wet liver weight. These results demonstrate that a quantitative correlation (r = 0.97, P < 0.001) exists between bile flow and the activity of the putative sodium pump. It should be emphasized however that although the correlation between (Na+-K+)-ATPase activity and bile flow, under many experimental conditions, is strong, it does not necessarily indicate an identity. These studies are consistent with previous studies demonstrating an association between bile flow and (Na+-K+)-ATPase for hepatic regeneration (79, 80) , selective biliary obstruction (81), rose bengal (69), icterogenin (82) , hypo-and hyperthyroidism (55) , chronic alcohol administration (77, 83) , ethinyl estradiol administration (50, 84) , and chlorpramazine (85) (86) (87) . Fturthermore, recent findings from this laboratory indicate that other drugs known to alter bile flow such as 6-methyl prednisolone, cortisone acetate, and pregnenolone-16-carbonitrile also increase (Na+-K+)-
ATPase.2
In concltusion, these studies demonstrate that the hepatic sodium pump adapts to phenobarbital therapy and other agents in accordance with its postulated role in transport of sodium across the bile canalicular membrane and regulation of bile salt-independent bile flow.
